Mariano Carrión‐Vázquez

This paper develops a preclinical treatment for PTSD using a peptide that blocks CPEB3 amyloid formation, reducing traumatic memory consolidation and PTSD-like symptoms in mice.

This paper demonstrates that the QBP1 peptide effectively inhibits hIAPP aggregation and protects β-cells from amyloid-induced toxicity in vitro.

The paper compares the amyloid-like assembly mechanisms of CPEB prion-like domains from Aplysia and Drosophila, showing divergent pathways leading to a common fold.

This paper investigates the molecular mechanisms of hCPEB3 liquid demixing and amyloidogenesis, identifying key regions and interactions involved in these processes.